These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

236 related articles for article (PubMed ID: 9864076)

  • 41. The effects of electroconvulsive therapy and antidepressant drugs on monoamine receptors in rodent brain--similarities and differences.
    Green AR; Heal DJ; Goodwin GM
    Ciba Found Symp; 1986; 123():246-67. PubMed ID: 3028726
    [TBL] [Abstract][Full Text] [Related]  

  • 42. S 16924 ((R)-2-[1-[2-(2,3-dihydro-benzo[1,4] dioxin-5-Yloxy)-ethyl]-pyrrolidin-3yl]-1-(4-fluoro-phenyl)-ethanone), a novel, potential antipsychotic with marked serotonin (5-HT)1A agonist properties: I. Receptorial and neurochemical profile in comparison with clozapine and haloperidol.
    Millan MJ; Gobert A; Newman-Tancredi A; Audinot V; Lejeune F; Rivet JM; Cussac D; Nicolas JP; Muller O; Lavielle G
    J Pharmacol Exp Ther; 1998 Sep; 286(3):1341-55. PubMed ID: 9732398
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Bupropion: a new antidepressant drug, the mechanism of action of which is not associated with down-regulation of postsynaptic beta-adrenergic, serotonergic (5-HT2), alpha 2-adrenergic, imipramine and dopaminergic receptors in brain.
    Ferris RM; Beaman OJ
    Neuropharmacology; 1983 Nov; 22(11):1257-67. PubMed ID: 6320035
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of pharmacologic treatments on the sleep of depressed patients.
    Sharpley AL; Cowen PJ
    Biol Psychiatry; 1995 Jan; 37(2):85-98. PubMed ID: 7718684
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Antidepressant activity of zinc: Further evidence for the involvement of the serotonergic system.
    Szewczyk B; Kotarska K; Siwek A; Olech Ł; Kuter K
    Pharmacol Rep; 2017 Jun; 69(3):456-461. PubMed ID: 28319749
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Rodent data and general hypothesis: antipsychotic action exerted through 5-Ht2A receptor antagonism is dependent on increased serotonergic tone.
    Martin P; Waters N; Schmidt CJ; Carlsson A; Carlsson ML
    J Neural Transm (Vienna); 1998; 105(4-5):365-96. PubMed ID: 9720968
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Agonist and antagonist actions of yohimbine as compared to fluparoxan at alpha(2)-adrenergic receptors (AR)s, serotonin (5-HT)(1A), 5-HT(1B), 5-HT(1D) and dopamine D(2) and D(3) receptors. Significance for the modulation of frontocortical monoaminergic transmission and depressive states.
    Millan MJ; Newman-Tancredi A; Audinot V; Cussac D; Lejeune F; Nicolas JP; Cogé F; Galizzi JP; Boutin JA; Rivet JM; Dekeyne A; Gobert A
    Synapse; 2000 Feb; 35(2):79-95. PubMed ID: 10611634
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [A new concept of antidepressant drugs action: clinical and preclinical data].
    Płaźnik A; Kostowski W
    Psychiatr Pol; 1994; 28(1):39-50. PubMed ID: 7910691
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Serotonin receptor changes after chronic antidepressant treatments: ligand binding, electrophysiological, and behavioral studies.
    Anderson JL
    Life Sci; 1983 Apr; 32(16):1791-801. PubMed ID: 6339859
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Chronic antidepressant therapy and associated changes in central monoaminergic receptor functioning.
    Sugrue MF
    Pharmacol Ther; 1983; 21(1):1-33. PubMed ID: 6312466
    [TBL] [Abstract][Full Text] [Related]  

  • 51. The serotonergic system in the neurobiology of depression: Relevance for novel antidepressants.
    Köhler S; Cierpinsky K; Kronenberg G; Adli M
    J Psychopharmacol; 2016 Jan; 30(1):13-22. PubMed ID: 26464458
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Pharmacology of antidepressants.
    Frazer A
    J Clin Psychopharmacol; 1997 Apr; 17 Suppl 1():2S-18S. PubMed ID: 9090573
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Addition of lithium to chronic antidepressant treatment potentiates presynaptic serotonergic function without changes in serotonergic receptors in the rat cerebral cortex.
    Okamoto Y; Motohasi N; Hayakawa H; Muraoka M; Yamawaki S
    Neuropsychobiology; 1996; 33(1):17-20. PubMed ID: 8821370
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Endocrine and receptor pharmacology of serotonergic anxiolytics, antipsychotics and antidepressants.
    Levy AD; Van de Kar LD
    Life Sci; 1992; 51(2):83-94. PubMed ID: 1352027
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Can we increase speed and efficacy of antidepressant treatments? Part I: General aspects and monoamine-based strategies.
    Artigas F; Bortolozzi A; Celada P
    Eur Neuropsychopharmacol; 2018 Apr; 28(4):445-456. PubMed ID: 29174531
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Neurochemical alterations of serotonergic neuronal systems in depression.
    Risch SC; Nemeroff CB
    J Clin Psychiatry; 1992 Oct; 53 Suppl():3-7. PubMed ID: 1331029
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Interactions between 5-hydroxytryptamine receptor subtypes: is a disturbed receptor balance contributing to the symptomatology of depression in humans?
    Berendsen HH
    Pharmacol Ther; 1995 Apr; 66(1):17-37. PubMed ID: 7630928
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Use of models for spontaneous paroxysmal activity in studies of adaptive changes in serotonin receptors].
    Bobula B; Zahorodna A; Tokarski K; Hess G
    Postepy Hig Med Dosw; 2002; 56(3):377-83. PubMed ID: 12194250
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Involvement of dopamine (DA)/serotonin (5-HT)/sigma (sigma) receptor modulation in mediating the antidepressant action of ropinirole hydrochloride, a D2/D3 dopamine receptor agonist.
    Dhir A; Kulkarni SK
    Brain Res Bull; 2007 Sep; 74(1-3):58-65. PubMed ID: 17683790
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Chronic antidepressant treatment alters serotonergic regulation of GABA transmission in prefrontal cortical pyramidal neurons.
    Zhong P; Yan Z
    Neuroscience; 2004; 129(1):65-73. PubMed ID: 15489029
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.